Acumen Pharmaceuticals, Inc. ($ABOS)
Filing Information
| Accession Number | 0001628280-26-003948 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 29, 2026 |
| Document Date | Jan 26, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
53,268
Total Value
$86,128.42
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer & Corp Sec | Common Stock | โ | Jan 26, 2026 | Exercise/Conversion | 15,085 | $1.85 | $27,907.25 | 189,084 | Direct | โ | View Details | |
Chief Legal Officer & Corp Sec | Common Stock | โ | Jan 26, 2026 | Sale | 15,085 | $3.00 | $45,262.54 | 173,999 | Direct | โ | View Details | |
Chief Legal Officer & Corp Sec | Common Stock | โ | Jan 28, 2026 | Exercise/Conversion | 2,671 | $1.85 | $4,941.35 | 176,670 | Direct | โ | View Details | |
Chief Legal Officer & Corp Sec | Common Stock | โ | Jan 28, 2026 | Sale | 2,671 | $3.00 | $8,017.27 | 173,999 | Direct | โ | View Details | |
Chief Legal Officer & Corp Sec | Employee Stock Option (right to buy) | Derivative | Jan 26, 2026 | Exercise/Conversion | 15,085 | $0.00 | $0.00 | 85,215 | Direct | โ | View Details | |
Chief Legal Officer & Corp Sec | Employee Stock Option (right to buy) | Derivative | Jan 28, 2026 | Exercise/Conversion | 2,671 | $0.00 | $0.00 | 82,544 | Direct | โ | View Details |